Toxoplasma gondii, IgG-13336

 

 

Test info

  
Toxoplasma gondii, IgG
  
13336
  
LAB13336
  
TOXOIGG
  
Toxoplasmosis antibodies
  
Index result quantitating IgG antibodies
  

Qualitative determination of IgG antibodies to Toxoplasma gondii (T. gondii) to aid in the determination of immune status of individuals including pregnant women.

Specimen

  
Serum
  
  
0.5 mL
  
0.2 mL
  

Immediatley following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  

Gold serum separator (SST) tube

  
  
  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection
  
  

Refrigerated (preferred) - 14 days

Ambient - 14 days

Frozen - 14 days

Freeze/thaw cycles: stable x4

  
  • Hemolysis
  • Lipemia
  • Gross bacterial contamination

Performance

  
LabCorp Burlington (006478): R-LC
  
Daily
  
1 - 2 days
Equivalent repeat, next run
  

Chemiluminescent immunoassay (CLIA)

Clinical and Interpretive info

  

Negative: <6.0 IU/mL

Equivocal:  6.0 - 7.9 IU/mL

Positive:   >7.9 IU/mL

  

Toxoplasma gondii is endemic in cats and is excreted by them in their feces. Humans are easily exposed to cyst forms, and the majority develop antibody without any clinical disease. A self-limiting lymphadenitis is the most common clinical presentation in symptomatic infection. Congenital toxoplasmosis and infections in AIDS patients are more serious.

Billing

  
86777
  
Result 5388-4

Tracking

  
04/11/2019
  
06/13/2023
  
05/30/2023